The DOI matches its Crossref record.
Nanoparticles: Characteristics, Mechanisms of Action, and Toxicity in Pulmonary Drug Delivery—A Review
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of neutral NPs as drug delivery vehicles is the most common approach in anti-TB therapy.206”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [206]
Citations
Cited by
Sorted by citations
Items 101–118 of 118
DESIGN AND OPTIMIZATION OF ACYCLOVIR LOADED SOLID LIPID NANOPARTICLES: A SUSTAINED RELEASE APPROACH
A., D. P., S, P. B., Kiruthika, S., et al. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i1.51877 · Cited by 1
“The model was confirmed by comparing predicted and observed values using the 95% confidence interval and P-value [12].”
Liposome as a versatile carrier for pulmonary drug delivery
Kumar, D. K., Gupta, S. L., Rajni, Bhatia, J. K., Kirti, K., & Faiyazuddin, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22374-7.00005-0 · Cited by 1
Nanoparticle-Plant Interactions
Hassan, S., Chinnam, S., Zahra, S. A., Nur, D., Bibi, N., Hayat, A., & Abbasi, B. A. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-4913-8.ch003 · Cited by 1
Sertraline-loaded targeted nanocarrier for breast cancer treatment: in vitro and in vivo assessment
Elsalhy, S., Tantawy, N., Hanafy, M. S., et al. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108342 · Cited by 1
Flower Shaped Silver Nanostructures: An Efficient Bacteria Exterminator
Chandra, S., Kanta, B., & Kumar, B. (2012) · InTech eBooks · doi:10.5772/45650 · Cited by 1
“Therefore, synthesis of nanoparticle under green and benign processes were adopted to produce toxic free nanoparticles (Zhang et al., 2007; Mohanpuria et al., 2008; Gill et al., 2007; Goodman et al. 2004; Jin et al. 2007; Singh and Nalwa, 2007; Kannan et al. 2006; Kattumuri et al. 2007).”
MethodNanoparticle Functionalization for Brain Targeting Drug Delivery and Diagnostic
Gomes, M. J., Mendes, B. B., Martins, S., & Sarmento, B. F. C. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-13188-7_42-1 · Cited by 1
Pereira, K. A. B., Mansur, C. R. E., & Jurgilas, P. B. (2024) · Revista Eletrônica Perspectivas da Ciência e Tecnologia · doi:10.22407/1984-5693.2024.v16.p.20241606
Ahne, J. (2019) · UWSpace (University of Waterloo) · Cited by 1
van Rensburg, L. (2012) · SUNScholar (Stellenbosch University)
Synthesis of rough-surface carriers for dry powder inhalation
Zhang, F. (2016) · doi:10.32657/10356/68855
“In addition, the relatively low enzymatic activity of the lung can help to maintain a higher bioavailability (8) compared to the enteral route and the non-invasive nature increases patient compliance (9).”
BackgroundYurdasiper, A., Arıcı, M., Azizoğlu, E., & Özyazıcı, M. (2016) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050077
Al-Hallak, M. K. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3rk6t
DEVELOPMENT AND CHARACTERIZATION OF NANOMATERIALS FOR PULMONARY DRUG DELIVERY APPLICATIONS
Guzmán, E. A. T. (2019) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-torrico-guzman-elisa-2019
Improved pulmonary drug delivery through nanocarriers
Shah, M. R., Imran, M., & Ullah, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821093-2.00008-6
Rasulev, B., Leszczyńska, D., & Leszczyński, J. (2014) · Nanotechnology · doi:10.4018/978-1-4666-5125-8.ch049
Liposomes for Delivery of Antitubercular Drugs
Shrivastava, P., Gautam, L., Vyas, S., & Vyas, S. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-14100-3_8 · Cited by 1
Carbon nanotubes for the management of chronic obstructive pulmonary disease
Sarath Chandran, C., Rahul, K., Sajayan, K., Shaji, A. K., Gopika Nath, C., Hiba Asrar, K., Muhammed, H., & Nair, R. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43946-9.00015-x
Metadata
- Authors
- Gill, S., Löbenberg, R., Ku, T., Azarmi, S., Roa, W., & Prenner, E. J.
- Venue
- Journal of Biomedical Nanotechnology
- Publisher
- American Scientific Publishers
- Published
- 2007-06-01
- Volume
- 3
- Issue
- 2
- Pages
- 107-119
- ISSN
- 1550-7033 (ISSN-L)
- 0000-0000
- OpenAlex
- W2329541536
- Cited by
- 118
- References
- 0
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 8 · 2015: 5 · 2014: 8 · 2013: 7 · 2012: 7
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Biomedical Nanotechnology (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- nanoparticles, pulmonary drug delivery, mechanism of action, nanoparticle toxicity, aerosolized nanoparticles, lung deposition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
